Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1652 INDUSTRY 1101 NIH 284 NETWORK 58 OTHER_GOV 33 UNKNOWN 4 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 53 Colorectal Neoplasms 42 Neoplasms 37 Lung Neoplasms 22 Breast Neoplasms 15 Colonic Neoplasms 14 Colonic Polyps 13 Rare Diseases 9 Carcinoma, Non-Small-Cell Lung 9 Carcinoma, Hepatocellular 9 Ovarian Neoplasms 7 Adenoma 7 Pulmonary Disease, Chronic Obstructive 6 Neoplasm Metastasis 6 Heart Failure 6 Rectal Neoplasms 5 Motor Activity 5 Liver Neoplasms 5 Head and Neck Neoplasms 5 Fibrosis 5 Carcinoma, Squamous Cell 5 Barrett Esophagus 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Neoplasms by Site 4 Mental Disorders 4 Lymphoma 4 Lung Diseases 4 Leukemia 4 Esophageal Neoplasms 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Melanoma × Clear all

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡